Contact

Minoryx

Minoryx

We are together in each step
Array ( [0] => WP_Term Object ( [term_id] => 964 [name] => BGI-Shenzhen [slug] => bgi-shenzhen [term_group] => 0 [term_taxonomy_id] => 964 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 238 [name] => biotecnología [slug] => biotecnologia [term_group] => 0 [term_taxonomy_id] => 238 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 22 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 417 [name] => e-health [slug] => e-health [term_group] => 0 [term_taxonomy_id] => 417 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 8 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 965 [name] => Freenome [slug] => freenome [term_group] => 0 [term_taxonomy_id] => 965 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [4] => WP_Term Object ( [term_id] => 966 [name] => genes [slug] => genes [term_group] => 0 [term_taxonomy_id] => 966 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [5] => WP_Term Object ( [term_id] => 967 [name] => genetica [slug] => genetica [term_group] => 0 [term_taxonomy_id] => 967 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [6] => WP_Term Object ( [term_id] => 968 [name] => genómica [slug] => genomica [term_group] => 0 [term_taxonomy_id] => 968 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [7] => WP_Term Object ( [term_id] => 153 [name] => global corporate finance [slug] => global-corporate-finance [term_group] => 0 [term_taxonomy_id] => 153 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 599 [filter] => raw ) [8] => WP_Term Object ( [term_id] => 969 [name] => GRAIL [slug] => grail [term_group] => 0 [term_taxonomy_id] => 969 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [9] => WP_Term Object ( [term_id] => 970 [name] => Guardant Health [slug] => guardant-health [term_group] => 0 [term_taxonomy_id] => 970 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [10] => WP_Term Object ( [term_id] => 971 [name] => inbiomotion [slug] => inbiomotion [term_group] => 0 [term_taxonomy_id] => 971 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [11] => WP_Term Object ( [term_id] => 972 [name] => kanteron [slug] => kanteron [term_group] => 0 [term_taxonomy_id] => 972 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [12] => WP_Term Object ( [term_id] => 202 [name] => M&A [slug] => ma [term_group] => 0 [term_taxonomy_id] => 202 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 35 [filter] => raw ) [13] => WP_Term Object ( [term_id] => 973 [name] => made of genes [slug] => made-of-genes [term_group] => 0 [term_taxonomy_id] => 973 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [14] => WP_Term Object ( [term_id] => 262 [name] => Minoryx [slug] => minoryx [term_group] => 0 [term_taxonomy_id] => 262 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [15] => WP_Term Object ( [term_id] => 974 [name] => Novogene [slug] => novogene [term_group] => 0 [term_taxonomy_id] => 974 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [16] => WP_Term Object ( [term_id] => 975 [name] => oryzon [slug] => oryzon [term_group] => 0 [term_taxonomy_id] => 975 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [17] => WP_Term Object ( [term_id] => 196 [name] => ronda de financiación [slug] => ronda-de-financiacion [term_group] => 0 [term_taxonomy_id] => 196 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 59 [filter] => raw ) [18] => WP_Term Object ( [term_id] => 726 [name] => ronda de inversión [slug] => ronda-de-inversion [term_group] => 0 [term_taxonomy_id] => 726 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 15 [filter] => raw ) )
2017, a record year for global investment in Genomics with major funding rounds
Genomics investment in 2017 has already surpassed last year's figure, boosted by large rounds of funding, with the number of [...]
read more >>
Minoryx y Sanifit reciben inversión de Caixa Capital Risk para luchar contra enfermedades raras.
El sector biotecnológico en general y el de las enfermedades raras en particular ha recibido el interés de Caixa Capit [...]
read more >>
closechevron-downcrossmenuchevron-down